Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Quon

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Cancer|December 11, 2012
Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrenceAllen S Ho, Gabriel J Tsao, Frank W Chen, et al.
Scientific Data|October 17, 2018
A radiogenomic dataset of non-small cell lung cancerShaimaa Bakr, Olivier Gevaert, Sebastian Echegaray, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
Most of the Intended Management Changes After <sup>68</sup>Ga-DOTATATE PET/CT Are ImplementedJeremie Calais, Johannes Czernin, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical RecurrenceJeremie Calais, Wolfgang P Fendler, Matthias Eiber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2020
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408Andrew M Evens, Fangxin Hong, Thomas M Habermann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 21, 2011
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancerMargaret M Kozak, James D Murphy, Meike L Schipper, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancerDevin Schellenberg, Jeff Kim, Claudia Christman-Skieller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2017
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancerMichael F Gensheimer, Julian C Hong, Christine Chang-Halpenny, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with <sup>177</sup>Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohortJeremie Calais, Andrei Gafita, Matthias Eiber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non-Small Cell Lung CancerFeng-Ming Spring Kong, Chen Hu, Daniel A Pryma, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Cancer|December 11, 2012
Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrenceAllen S Ho, Gabriel J Tsao, Frank W Chen, et al.
Scientific Data|October 17, 2018
A radiogenomic dataset of non-small cell lung cancerShaimaa Bakr, Olivier Gevaert, Sebastian Echegaray, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2017
Most of the Intended Management Changes After <sup>68</sup>Ga-DOTATATE PET/CT Are ImplementedJeremie Calais, Johannes Czernin, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical RecurrenceJeremie Calais, Wolfgang P Fendler, Matthias Eiber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2020
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408Andrew M Evens, Fangxin Hong, Thomas M Habermann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 21, 2011
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancerMargaret M Kozak, James D Murphy, Meike L Schipper, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancerDevin Schellenberg, Jeff Kim, Claudia Christman-Skieller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2017
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancerMichael F Gensheimer, Julian C Hong, Christine Chang-Halpenny, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with <sup>177</sup>Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohortJeremie Calais, Andrei Gafita, Matthias Eiber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non-Small Cell Lung CancerFeng-Ming Spring Kong, Chen Hu, Daniel A Pryma, et al.
Pageof 10